MEDNAX (MD) Tops Q4 EPS by 4c, Beats on Revenues; 1Q18 EPS Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mednax (MD) PT Raised to $57 at Citi
February 12, 2018 6:22 AM ESTCiti raised its price target on Mednax (NYSE: MD) to $57.00 (from $47.00) while maintaining a Neutral rating.
... MoreMednax (MD) PT Raised to $62 at Stephens; Reiterates Overweight
February 9, 2018 8:05 AM ESTStephens raised its price target on Mednax (NYSE: MD) to $62.00 (from $55.00) while maintaining a Overweight rating following the company's 4Q earnings report. The 4Q17 adjusted EBITDA margin declined 340bps to 17% Y/Y driven entirely by a 360bps increase in Practice Salaries and Benefits to 67.8%. Organic... More
